Innovent Biologics, Inc. (IVBXF)
USD 6.88
(25.23%)
USD 6.88
(25.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.67 Billion CNY | 19.03% |
| 2022 | -2.07 Billion CNY | 33.38% |
| 2021 | -3.11 Billion CNY | -279.55% |
| 2020 | -820.13 Million CNY | 50.69% |
| 2019 | -1.66 Billion CNY | 71.35% |
| 2018 | -5.8 Billion CNY | -732.94% |
| 2017 | -697.02 Million CNY | -37.03% |
| 2016 | -508.65 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -44.92 Million USD | 0.0% |
| 2023 Q1 | -52.33 Million USD | 75.04% |
| 2023 FY | -1.67 Billion CNY | 19.03% |
| 2023 Q4 | -78.42 Million USD | -35.51% |
| 2023 Q3 | -57.87 Million USD | 9.18% |
| 2023 Q2 | -63.72 Million USD | -21.76% |
| 2022 Q2 | -186.46 Million USD | 0.0% |
| 2022 FY | -2.07 Billion CNY | 33.38% |
| 2022 Q4 | -209.71 Million USD | -78.27% |
| 2022 Q3 | -117.63 Million USD | 36.91% |
| 2021 FY | -3.11 Billion CNY | -279.55% |
| 2021 Q4 | -245.25 Million USD | 0.0% |
| 2021 Q2 | -125.66 Million USD | 0.0% |
| 2020 FY | -820.13 Million CNY | 50.69% |
| 2020 Q4 | 69.19 Million USD | 0.0% |
| 2020 Q2 | -91.4 Million USD | 0.0% |
| 2019 Q4 | -156.57 Million USD | 0.0% |
| 2019 FY | -1.66 Billion CNY | 71.35% |
| 2019 Q2 | -107.09 Million USD | 0.0% |
| 2018 FY | -5.8 Billion CNY | -732.94% |
| 2017 FY | -697.02 Million CNY | -37.03% |
| 2016 FY | -508.65 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.16 Million USD | -52903.654% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -180202.454% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -63811.967% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -9309.43% |
| GB Sciences, Inc. | -1.42 Million USD | -118118.258% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -49218.983% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -762948.101% |
| Skye Bioscience, Inc. | -13.67 Million USD | -12182.955% |
| Zenith Capital Corp. | -8.94 Million USD | -18677.826% |
| Agentix Corp. | -1.37 Million USD | -122319.804% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -33189.853% |
| Biomind Labs Inc. | -1 Million USD | -166232.806% |
| ContraFect Corporation | -56.88 Million USD | -2851.891% |
| CSL Limited | 3.7 Billion USD | 145.362% |
| CytoDyn Inc. | -18.05 Million USD | -9199.485% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -89973.376% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -430965.277% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -2925.331% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -404084.327% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -109226.005% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -244357.53% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 2151.633% |
| SQZ Biotechnologies Company | -75.82 Million USD | -2114.706% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -84436.559% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -2239.315% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -58812.362% |
| Mesoblast Limited | -84.14 Million USD | -1895.675% |
| Marizyme, Inc. | -34.08 Million USD | -4826.584% |
| Genus plc | 6.4 Million USD | 26339.078% |
| Pharming Group N.V. | -4.87 Million USD | -34315.122% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -20011.389% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -119679.728% |
| IMV Inc. | -38.67 Million USD | -4242.476% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -60946.866% |
| MultiCell Technologies, Inc. | -722.81 USD | -232329419.514% |
| ONE Bio Corp. | 13.68 Million USD | 12374.202% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -2746.755% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 47537.881% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -57781.982% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -25160.187% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -5606540.625% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -10481.782% |
| Alpha Cognition Inc. | -9.7 Million USD | -17202.391% |
| Enzolytics Inc. | -2.14 Million USD | -78050.642% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | -295.084% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -160752.586% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -57421.261% |
| Genscript Biotech Corporation | -415.79 Million USD | -303.881% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 34268.17% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -641525.593% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -68294.468% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -979029.791% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -83665.813% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 17336.932% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -36769.419% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -44724.164% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -170551.479% |
| EV Biologics, Inc. | -483.06 Thousand USD | -347536.742% |
| Q BioMed Inc. | -3.44 Million USD | -48637.323% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -133602.309% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -2954.81% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | -21487.707% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -86792.906% |
| HST Global, Inc. | -140.9 Thousand USD | -1191679.684% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -125649.739% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -149183.673% |
| Halberd Corporation | -75.05 Thousand USD | -2237476.282% |
| Resverlogix Corp. | -12.74 Million USD | -13072.021% |
| Cell Source, Inc. | -4.32 Million USD | -38724.663% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -106228.28% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 6.69 Million USD | 25190.858% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -9639421.267% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | -67977.194% |
| Kadimastem Ltd | -3.04 Million USD | -55135.622% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -39520.976% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -925211.183% |
| LadRx Corporation | -3.82 Million USD | -43819.071% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -244357.53% |
| Affymax, Inc. | -15.04 Million USD | -11061.113% |
| Itoco Inc. | -919.14 Thousand USD | -182603.505% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -149971.582% |
| Mobile Lads Corp. | -554.55 Thousand USD | -302722.288% |
| International Stem Cell Corporation | -663 Thousand USD | -253188.235% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -3.82 Million USD | -43859.068% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -6671735.518% |
| Qrons Inc. | -643.67 Thousand USD | -260791.876% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -297267.205% |
| SYBLEU INC | -149.18 Thousand USD | -1125587.76% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -75209.064% |
| Rebus Holdings, Inc. | -664 Thousand USD | -252806.777% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -92356.23% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3190061.474% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -8256050.442% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -4530.511% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -103688.69% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -228117.06% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -53879.46% |
| Neutra Corp. | -229.48 Thousand USD | -731666.208% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -9474.668% |
| PureTech Health plc | -146.19 Million USD | -1048.641% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -7713.93% |
| IXICO plc | -1.43 Million USD | -116761.587% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -17593.615% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -1278.669% |
| CSL Limited | 3.81 Billion USD | 144.053% |
| Cellectis S.A. | -108.85 Million USD | -1442.662% |